GPT and metabolic dysfunction-associated steatotic liver disease: Despite the high prevalence of NAFLD in the PCOS patients, only 26 (12.0%) of all PCOS patients in this study had abnormally elevated ALT (> 40 U/L), and only 23 (30.3%) of the 76 patients with both PCOS and NAFLD had abnormally elevated ALT.